Literature DB >> 6715765

Low triiodothyronine and raised reverse triiodothyronine levels in patients over fifty years of age who have type II diabetes mellitus: influence of metabolic control, not age.

U M Kabadi, B N Premachandra.   

Abstract

Several studies have demonstrated that the uncontrolled diabetic state in both type I as well as type II diabetes mellitus is characterized by altered thyroid hormone metabolism, which results in the lowering of serum triiodothyronine (T3) levels and a reciprocal elevation of T3 (rT3) levels. Because the majority of type II diabetics are over 50 years of age and because numerous previous reports have implicated aging as a cause of low T3 and high rT3 levels, we studied 220 type II diabetics from 40-85 years of age to assess the influence of aging and metabolic control on thyroid hormone levels. Serum thyroxine (T4) free T4, T3 resin uptake, and thyroid-stimulating hormone (TSH) measurements in diabetic patients were not significantly altered compared with 37 young normal control subjects, irrespective of age or the grade of metabolic control. Serum T3 levels declined and rT3 levels rose in the diabetic patients with worsening of the metabolic control. However, with comparable metabolic control, the levels were not significantly different from the younger patients. Therefore, low T3 and high rT3 levels observed in patients of any age who have type II diabetes mellitus may be exclusively caused by deranged metabolic control of their disease.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6715765     DOI: 10.1111/j.1532-5415.1984.tb02043.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  3 in total

1.  Relation of thyroid hormone abnormalities with subclinical inflammatory activity in patients with type 1 and type 2 diabetes mellitus.

Authors:  Arnaldo Moura Neto; Maria Candida Ribeiro Parisi; Sarah Monte Alegre; Elizabeth Joao Pavin; Marcos Antonio Tambascia; Denise Engelbrecht Zantut-Wittmann
Journal:  Endocrine       Date:  2015-06-07       Impact factor: 3.633

2.  Relationship of thyroid hormone levels and cardiovascular events in patients with type 2 diabetes.

Authors:  A Moura Neto; M C R Parisi; M A Tambascia; E J Pavin; S M Alegre; D E Zantut-Wittmann
Journal:  Endocrine       Date:  2013-04-02       Impact factor: 3.633

3.  Identification of a novel modulator of thyroid hormone receptor-mediated action.

Authors:  Bernhard G Baumgartner; Meritxell Orpinell; Jordi Duran; Vicent Ribas; Hans E Burghardt; Daniel Bach; Ana Victoria Villar; José C Paz; Meritxell González; Marta Camps; Josep Oriola; Francisca Rivera; Manuel Palacín; Antonio Zorzano
Journal:  PLoS One       Date:  2007-11-21       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.